Company Overview and News

Kwun Tong residential site attracts 25 bids despite concerns over infrastructure capacity

2018-01-19 scmp
Developers’ enthusiasm for land tenders has shown no signs of easing – a residential site in Hong Kong’s Kwun Tong has attracted stronger than expected interest. But valuers said infrastructure in the region might not be able to support the extra population.

Lai Sun Development’s chairman makes first buy-back since Asian financial crisis of 1997

2017-12-03 scmp
Buying on the Hong Kong stock exchange fell for the first time in four weeks while selling among directors declined for the second straight week, based on filings from November 27 to December 1.

International school to open in Hengqin as part of Novotown expansion, says Lai Fung

2017-09-26 scmp
After forming a partnership with Spanish football club Real Madrid Club de Futol to expand its Novotown cultural and entertainment project in Zhuhai’s Hengqin, Lai Fung Holdings chairman Chew Fook Aun is in talks with a well known international school.

Thank you Henderson: Record Murray Road price lifts property values in the neighbourhood

2017-05-17 scmp
Cheung Kong Property, whose Hutchison House is across the Lambeth Walk from Murray Road, could see its net asset value per share boosted by HK$5, according to JPMorgan.

Redevelopment of Mariners’ Club in Tsim Sha Tsui draws strong response from developers

2017-04-04 scmp
The proposed redevelopment of the 50-year old Mariners’ Club in Tsim Sha Tsui has generated enthusiastic initial response from developers ahead of the official tender, the club’s operator said.

Hong Kong home buyers thumb their noses at increased prices

2017-03-12 scmp
Two property projects launched over the weekend reported worse-than-expected sales results, as their increased prices found few takers

Walter Kwok building property holdings in Hong Kong

2016-10-11 scmp
His Empire Group has invested some HK$7bn into the city’s real estate sector since its creation in 2010

Launch of latest Hong Kong tiny flats fails to draw long queues ahead of US interest rate decision

2016-09-20 scmp
Prospective buyers jostled for a batch of tiny Hong Kong flats put up for sale on Tuesday, ahead of a two day meeting by the US Federal Reserve to discuss a possible interest rate increase, but fewer than expected people turned out.

Hong Kong property sales leap 35 per cent as investors join buying frenzy

2016-09-16 scmp
Midland Realty predicts overall property deals will surpass 8,000 this month, the highest monthly figure since February, 2015

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...